Drug: |
Ripretinib |
|||
---|---|---|---|---|
Trial: |
A Phase 3 Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib (INSIGHT) |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
McGill University |
Principal Investigator: |
|
---|---|
Contact: |
|
Activation Status of this Site: |
Active |
Notes about this Site: |
|
McGill University Website: |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.